Related Experiment Video
Updated: Jun 12, 2025
07:50
Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish
Published on: July 16, 2012
14.2K
Marine Microorganism Molecules as Potential Anti-Inflammatory Therapeutics
Malia Lasalo1, Thierry Jauffrais2, Philippe Georgel3
1Group Bioactivities of Natural Compounds and Derivatives (BIONA), Institut Pasteur of New Caledonia, Member of the Pasteur Network, Noumea 98845, New Caledonia.
Marine Drugs
|September 27, 2024
Summary
Marine microorganisms are a rich source of novel anti-inflammatory compounds. This review explores marine natural products (MNPs) and their potential for developing new drugs to combat inflammation.
Area of Science:
- Marine Biology
- Pharmacology
- Natural Product Chemistry
Background:
- The marine environment harbors vast unexplored biodiversity with significant pharmacological potential.
- Marine natural products (MNPs), including immunomodulators, have been identified, highlighting their therapeutic promise.
- Marine microorganisms are a key source of bioactive molecules with potential applications in medicine.
Purpose of the Study:
- To review the potential of marine microorganisms as a source for novel anti-inflammatory compounds.
- To describe marine natural products (MNPs) with immunomodulatory potential and their biological targets.
- To discuss the challenges in discovering anti-inflammatory compounds from marine microorganisms.
Main Methods:
- Literature review of scientific publications on marine natural products and their bioactivity.
- Analysis of identified MNPs with immunomodulatory and anti-inflammatory properties.
- Examination of biological targets and mechanisms of action for relevant MNPs.
Main Results:
- Numerous MNPs derived from marine microorganisms exhibit significant immunomodulatory and anti-inflammatory effects.
- Specific examples of MNPs and their targeted biological pathways are detailed.
- The potential for developing novel anti-inflammatory drugs from marine microbial sources is substantial.
Conclusions:
- Marine microorganisms represent a promising, yet underexplored, reservoir for discovering novel anti-inflammatory agents.
- Further research into MNPs can lead to the development of new therapeutic strategies for inflammatory diseases.
- Overcoming challenges in marine microbial compound discovery is crucial for unlocking this potential.
Related Concept Videos
01:23Antimicrobial Proteins
947
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
947
01:29Drugs for Treatment of Ulcerative Colitis in IBD
129
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
129
01:22MicroRNAs
21.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.2K
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
119
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
119
01:28Inflammatory Response
1.9K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
1.9K
01:29Inflammatory Bowel Disease IV: Pharmacological Management
118
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
118